UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040054
Receipt number R000045668
Scientific Title The efficacy of the popliteal plexus block for total knee arthroplasty; the comparison with the tibial nerve block
Date of disclosure of the study information 2020/04/04
Last modified on 2023/04/13 22:25:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of the popliteal plexus block for total knee arthroplasty; the comparison with the tibial nerve block

Acronym

The efficacy of the popliteal plexus block for total knee arthroplasty; the comparison with the tibial nerve block

Scientific Title

The efficacy of the popliteal plexus block for total knee arthroplasty; the comparison with the tibial nerve block

Scientific Title:Acronym

The efficacy of the popliteal plexus block for total knee arthroplasty; the comparison with the tibial nerve block

Region

Japan


Condition

Condition

knee osteoarthritis or knee rheumatoid arthritis

Classification by specialty

Orthopedics Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim is to clarify the equivalent or non-inferior efficacy of the early discharge after total knee arthroplasty using popliteal plexus block or tibial nerve block for the reduction of the dorsal aspect of the knee.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Early discharge readiness
2.

Key secondary outcomes

Postoperative pain score (NRS): Postoperative 1 hour, time point per 12 hours till postoperative 72 hours)
Postoperative motor function (24, 48, 72 hours)
Postoperative rehabilitation score and muscle power(24, 48, 72 hours)
Consumption of postoperative additional analgesics(72 hours)
Complication(72 hours)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Popliteal Plexus Block with 0.25% levobupivacaine 10 mL

Interventions/Control_2

Tibial Nerve Block(TNB) with 0.25% levobupivacaine 10 mL

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1.Patients scheduled unilateral total knee arthroplasty at Daiyukai General Hospital
2.Adults (>=20 years) with American Society of Anaesthesiologists Physical Status Classification I-III
3.Participants were scheduled for primary unilateral TKA for osteoarthritis
4.Written informed consent is provided

Key exclusion criteria

1.Inability to communicate lucidly
2.Bilateral TKA
3.revision knee arthroplasty
4.Under 20 years old
5.Allergy to any of the drugs used in this study
6.ASA-PS > III
7.Chronic opioid use
8.Diabetes mellitus with sensory disorders
9.Neurological disability
10.Infections around femoral crease
11.Platelet < 5.0 * 10^4 /mcl
12.Pregnancy, possibility of pregnancy, or breast-feeding women
13.Contraindications to peripheral nerve blocks

Target sample size

136


Research contact person

Name of lead principal investigator

1st name Norihiro
Middle name
Last name Sakai

Organization

Daiyukai General Hospital

Division name

Dep. Anaesthesiplogy

Zip code

491-8551

Address

1-9-9, Sakura, Ichinomiya, Aichi, Japan

TEL

+81-586-72-1211

Email

sakayline@anes.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Norihiro
Middle name
Last name Sakai

Organization

Daiyukai General Hospital

Division name

Dep. Anaesthesiplogy

Zip code

491-8551

Address

1-9-9, Sakura, Ichinomiya, Aichi, Japan

TEL

+81-586-72-1211

Homepage URL

http://www.wb.commufa.jp/dykmasui/

Email

sakayline@anes.med.osaka-u.ac.jp


Sponsor or person

Institute

Daiyukai General Hospital

Institute

Department

Personal name



Funding Source

Organization

Daiyukai General Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institution of Review Board of Daiyukai general Hospital

Address

1-9-9, Sakura, Ichinomiya, Aichi, Japan

Tel

+81-586-72-1211

Email

extensor2@yahoo.co.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2020-001

Org. issuing International ID_1

Daiyukai General Hospital

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

総合大雄会病院


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 04 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045668

Publication of results

Published


Result

URL related to results and publications

now preparing

Number of participants that the trial has enrolled

132

Results

The discharge criteria durations were 49.7(10.5) and 47.4(9.7) hours in TNB and PPB groups, respectively, with a mean difference of -2.3 hours (95% CI: -5.8 to 1.2 hours; P = 0.20).

Results date posted

2023 Year 04 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

PPB TNB
Sample size, n 67 65
Patient characteristics
Gender, n (%)
Male 20 (29.9) 20 (30.8)
Female 47 (60.1) 45(69.2)
ASA status, n (%)
I 8 (11.9) 4 (6.2)
II 56 (83.6) 57 (87.6)
III 3 (4.5) 4 (6.2)
Left and Right, n (%)
Left 43 (64.1) 32 (49.2)
Right 24 (35.9) 33 (50.8)
Mean age (SD) in years 76 (8) 75 (7)
Mean height (SD) in cm 154 (6) 154 (10)
Mean weight (SD) in kg 60 (10) 60 (11)
Mean BMI (SD) in kg/m2 25.0 (3.3) 25.4 (3.5)
Preoperative knee flexion (SD), degree 126 (13) 123 (15)
Surgical values
Mean duration of surgery (SD) in minutes 114 (17) 115 (16)
Mean duration of operation room occupied (SD) in minutes 165 (19) 167 (19)
Mean duration of tourniquet ischemia (SD) in minutes 105 (13) 107 (11)
Mean bleeding (SD) in mL 129 (75) 114 (56)
mean water balance (SD) in mL 722 (267) 716 (241)

Participant flow

We included 136 patients with TKA meeting the inclusion criteria (Figure 1). Data from 132 patients were analyzed; 4 were excluded because of protocol violations during surgery, including 1 in the PPB group and 3 in the TNB group. The patient demographics of the groups were not significantly different (P > 0.05) (Table 1).

Adverse events

Postoperative nausea and vommiting 3/132
Falling 0/132
Pruitus 0/132

Outcome measures

The primary endpoint was the time to fulfill the discharge criteria of an NRS of under 4 at rest, 30-meter ambulation using a walker, and the ability to perform 90 degree knee flexion.4,6 The secondary endpoints included evaluating NRS scores at rest and during rehabilitation using supplementary analgesics, postoperative SLR test results at 1, 24, 48, and 72 hours, as well as the time required to achieve deep knee flexion (120 degrees and over), assessing muscle strength, and adverse effects including postoperative nausea and vomiting, postoperative falling, and pruritus.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 15 Day

Date of IRB

2020 Year 03 Month 04 Day

Anticipated trial start date

2020 Year 04 Month 06 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2020 Year 04 Month 04 Day

Last modified on

2023 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045668


Research Plan
Registered date File name
2023/12/14 Protocol_231212.pdf

Research case data specifications
Registered date File name
2023/06/16 Research Case Data Specifications.pdf

Research case data
Registered date File name
2023/06/16 RawData_230616_Public.csv